Medicine
Vectibix 400 mg/20 mL injection
Vectibix 400 mg/20 mL injection is a prescription medicine containing Panitumumab for intravenous use, marketed by Amgen, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store vials in the original carton under refrigeration at 2° to 8°C (36° to…
Key facts
- Active ingredient (INN)
- Panitumumab
- Brand
- Vectibix
- Strength
- 400 mg/20 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 1 vial of 20 mL
- Marketing authorisation holder
- Amgen
- Manufacturer
- Amgen
- Origin register
- US FDA, United States
- Storage
- Store vials in the original carton under refrigeration at 2° to 8°C (36° to 46°F) until time of use. Do not freeze or shake. Protect from direct sunlight.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01XC08 Panitumumab
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 10 October 2006
- Identifiers
- RxCUI 1657703, 1657705, 1657722 +1DailyMed set ID e0fa4bca-f245-4d92-ae29-b0c630a315c2NDC 55513-956Application BLA125147
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Panitumumab
Clinical summary
Panitumumab is an epidermal growth factor receptor antagonist indicated for the treatment of adult patients with wild-type RAS (defined as wild-type in both KRAS and NRAS as determined by an FDA-approved test) Metastatic Colorectal Cancer (mCRC)*. MedsAcross supplies Panitumumab for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PanitumumabFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Vectibix prescribing information (Amgen) · U.S. National Library of Medicine, DailyMed
- Vectibix: European public assessment report (EPAR) · European Medicines Agency
Need Vectibix 400 mg/20 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.